Search results

Meeting held at 9:00am at Stella House, Newcastle Upon Tyne. Present: Sue Douthwaite, ChairMichael Brodie, Chief ExecutiveKathy Gillatt, Non-Executive DirectorDavid Leather, Non-Executive DirectorMathew McKie, Non-Executive DirectorMel…

By using the Buy an NHS PPC service means you agree to the following terms and conditions.Definitions'You' means the person named on the PPC.Legal identityThe NHS Business Services Authority (NHSBSA). We are an Arm's Length Body of the…

The lifetime allowance is changing On 15 March 2023, the Chancellor of the Exchequer announced changes to the lifetime allowance to support workforce retention. The lifetime allowance charge will be removed from 6 April 2023 and abolished in…

Introduction This section explains the use of Assumed Daily Doses (ADDs) for measuring medicine utilisation in the Innovation Scorecard. It discusses why ADDs are used, how they are used in calculations, and the principles applied to assign ADDs.…

Introduction This section explains the use of Assumed Daily Doses (ADDs) for measuring medicine utilisation in the Innovation Scorecard. It discusses why ADDs are used, how they are used in calculations, and the principles applied to assign ADDs.…

Introduction This section explains the use of Assumed Daily Doses (ADDs) for measuring medicine utilisation in the Innovation Scorecard. It discusses why ADDs are used, how they are used in calculations, and the principles applied to assign ADDs.…

Introduction This section explains the use of Assumed Daily Doses (ADDs) for measuring medicine utilisation in the Innovation Scorecard. It discusses why ADDs are used, how they are used in calculations, and the principles applied to assign ADDs.…

IntroductionThis section explains the use of Assumed Daily Doses (ADDs) for measuring medicine utilisation in the Innovation Scorecard. It discusses why ADDs are used, how they are used in calculations, and the principles applied to assign ADDs. The…